Printer Friendly

Completion of a non-exclusive discount agreement pursuant to A* 130a sgb v, section 8 to the active substance zoledronic acid 5 mg/100 ml as a transitional arrangement.

Contract notice: Completion of a non-exclusive discount agreement pursuant to A* 130a sgb v, section 8 to the active substance zoledronic acid 5 mg/100 ml as a transitional arrangement.

The GWQ Service Plus AG intends to conduct a Europe-wide, open tender process for the active ingredient in the potency of zoledronic acid 5 mg/100 ml with contract start to 1.4.2014. For the period up to 31.3.2014 GWQ Service Plus AG intends to close non-exclusive discount agreements pursuant to A* 130a SGB V, Section 8 of this drug. Until the start of exclusive contracts this transitional arrangement is open to accession by all market participants, but the last time due to the time limits for 1/10/2014. The contract documents, the turnover of the participating funds as well as the dates for notification of the contract award are available on the portal of the GWQ Service Plus AG http://vergabeportal.gwq-serviceplus.de after registration and herunterzuladen.

Time limit for receipt of tenders or requ

Tender documents : T16123088.html

2013 Al Bawaba (Albawaba.com)

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2013 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Date:May 14, 2013
Words:187
Previous Article:Provision for Pharmaceutical products.
Next Article:Construction of a comprehensive school - structural design.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters